Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week randomized placebo-controlled study of AVE8134 in untreated adults with type 2 diabetes mellitus
2005-005141-19Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing AVE8134 with Placebo (2 arms). Primary endpoint: Change in hemoglobin A1c. Started Feb 2006; status: completed.
02
Drugs
AVE8134
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-005141-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005141-19.